Literature DB >> 18271019

Detection of T-regulatory cells has a potential role in the diagnosis of classical Hodgkin lymphoma.

David S Bosler1, Vonda K Douglas-Nikitin, Valerie N Harris, Marc D Smith.   

Abstract

Previous studies have demonstrated an increase in T-regulatory cells in the involved lymph nodes and peripheral blood of patients with Hodgkin lymphoma. Our study examined whether the detection of T-regulatory cells by flow cytometry could distinguish classical Hodgkin lymphoma (CHL) from benign cases and B-cell non-Hodgkin lymphomas (B-NHL). We measured CD4, CD25, and CD152 in 14 CHLs, 2 nodular lymphocyte-predominant Hodgkin lymphomas, 31 B-NHLs, and 54 benign cases. All T-regulatory cell parameters, including percent lymphocytes CD4+/CD152+ and CD4+/CD25+/CD152+, and mean and median CD152 expression in CD4+/CD25+ lymphocytes, were higher in CHL than in B-NHL and benign. Mean CD152 in CD4+/CD25+ lymphocytes distinguished CHL from benign with 79% sensitivity and 100% specificity, and from B-NHL with 71% sensitivity and 90% specificity. Overall, our results show that T-regulatory cells are increased in CHL and their detection may be a useful tool in differentiating CHL from other entities. (c) 2008 Clinical Cytometry Society

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18271019     DOI: 10.1002/cyto.b.20407

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  10 in total

1.  Organ Specific Tumor Markers: What's New?

Authors:  Kannan Vaidyanathan; D M Vasudevan
Journal:  Indian J Clin Biochem       Date:  2011-11-08

2.  Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications.

Authors:  Mikhail Roshal; Brent L Wood; Jonathan R Fromm
Journal:  Adv Hematol       Date:  2010-11-28

3.  T-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications.

Authors:  Claudio Fozza; Maurizio Longinotti
Journal:  Adv Hematol       Date:  2010-10-12

4.  Flow cytometry for assessment of the tumor microenvironment in pediatric Hodgkin lymphoma.

Authors:  Meret Henry; Steven Buck; Süreyya Savaşan
Journal:  Pediatr Blood Cancer       Date:  2018-07-15       Impact factor: 3.167

Review 5.  Immunological deregulation in classic hodgkin lymphoma.

Authors:  Alessandra Romano; Calogero Vetro; Giovanni Caocci; Marianna Greco; Nunziatina Laura Parrinello; Francesco Di Raimondo; Giorgio La Nasa
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-06-01       Impact factor: 2.576

6.  The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein-Barr virus presence and location within the tumor.

Authors:  R Wu; A Sattarzadeh; B Rutgers; A Diepstra; A van den Berg; L Visser
Journal:  Blood Cancer J       Date:  2016-05-06       Impact factor: 11.037

7.  Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.

Authors:  Lydia Visser; Bea Rutgers; Arjan Diepstra; Anke van den Berg; Ahmad Sattarzadeh
Journal:  Int J Mol Sci       Date:  2016-12-16       Impact factor: 5.923

8.  Flow cytometry assessment of reactive T-cells distinguishes classic Hodgkin lymphoma from benign lymphadenopathy in children.

Authors:  Hui Gao; Fengqing Cai; Lei Liu; Hongqiang Shen
Journal:  J Clin Lab Anal       Date:  2022-08-21       Impact factor: 3.124

9.  Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas.

Authors:  Debmalya Barh; Sandeep Tiwari; Lucas Gabriel Rodrigues Gomes; Marianna E Weener; Khalid J Alzahrani; Khalaf F Alsharif; Alaa A A Aljabali; Murtaza M Tambuwala; Kenneth Lundstrom; Sk Sarif Hassan; Ángel Serrano-Aroca; Kazuo Takayama; Preetam Ghosh; Elrashdy M Redwan; Bruno Silva Andrade; Siomar de Castro Soares; Vasco Azevedo; Vladimir N Uversky
Journal:  Viruses       Date:  2021-09-25       Impact factor: 5.048

10.  De Novo Identification and Visualization of Important Cell Populations for Classic Hodgkin Lymphoma Using Flow Cytometry and Machine Learning.

Authors:  Paul D Simonson; Yue Wu; David Wu; Jonathan R Fromm; Aaron Y Lee
Journal:  Am J Clin Pathol       Date:  2021-11-08       Impact factor: 5.400

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.